JPMorgan Chase & Co’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2K | Sell |
1,762
-7,519
| -81% | -$9.4K | ﹤0.01% | 5640 |
|
|
2025
Q1 | $30K | Sell |
9,281
-32,163
| -78% | -$104K | ﹤0.01% | 5174 |
|
|
2024
Q4 | $171K | Buy |
41,444
+37,980
| +1,096% | +$156K | ﹤0.01% | 4593 |
|
|
2024
Q3 | $22.2K | Buy |
3,464
+1,414
| +69% | +$9.08K | ﹤0.01% | 5189 |
|
|
2024
Q2 | $9.86K | Sell |
2,050
-555
| -21% | -$2.67K | ﹤0.01% | 5261 |
|
|
2024
Q1 | $13.6K | Buy |
+2,605
| New | +$13.6K | ﹤0.01% | 5301 |
|